Comparison between Two-Photon Treatment Planning Techniques 3D-Conformal Radiotherapy and the Volumetric Modulated Arc Therapy for Head and Neck Carcinoma

Document Type : Original Paper

Authors

1 Higher Institute of Nursing Professions and Health Techniques, Ministry of Health and Social Protection, Rabat-Morocco

2 Radiotherapy Department, National Institute of Oncology, University Mohamed V, Rabat - Morocco

10.22038/ijmp.2024.78807.2394

Abstract

Introduction: Achieving precise dose delivery in head and neck cancer is challenging, requiring effective tumor control while minimizing toxicity. This study compares Volumetric-Modulated Arc Therapy (VMAT) and 3D Conformal Radiotherapy (3D-CRT), focusing on target coverage, Organs At Risk (OARs) sparing and treatment efficiency.
Material and Methods: For 7 randomly selected patients, Two plans (3D-CRT and VMAT) were created using Monaco TPS. The prescribed doses were 70/63/56Gy for Five patients and 69.96/59.4/54Gy for Two, in 35 and 33 fractions. The t-test was used for statistical analysis. VMAT plans underwent pretreatment quality control.
Results: The mean Dmean, Dmax, and V95% of PTV70Gy were 70.86/70.23Gy, 78.95/75.28Gy, and 95.35% / 96.97% for 3D-CRT and VMAT. The Dmax for the spinal cord, brainstem and chiasma were 49.98/40.76Gy, 64.05/50.00Gy, and 54.27/47.78Gy. The mean dose for the Left (L) and Right (R) parotids was 66.93/44.18Gy and 67.79/44.98Gy. The Dmax for L/R optic nerves and eyes were 60.17/50.41Gy, 59.44/48.49Gy, 48.4/39.88, and 44.09/36.93Gy. The 0.03cc of the L/R temporal lobes received 73.37/69.59Gy and 73.17/68.33Gy. The mean dose in 2cc of the mandible was 72.88/66.99Gy. The mean volume of the larynx with 66Gy was 23.72% / 0.76%. The Homogeneity and Conformity Index were 0.12/0.08 and 0.95/0.97. The treatment time and MUs for 3D-CRT/VMAT were 3.35/6.36 min and 806.86/621.53 MUs. VMAT gamma index passing rate was 98.6%.  
Conclusion: The VMAT limits irradiation, reduces OARs toxicity, assures higher target dose and avoids cold and hot spots. This study shows that VMAT provides superior normal tissue protection as compared to 3D-CRT.

Keywords

Main Subjects


  1. Lee N, Xia P, Fiscbein NJ. IMRT for head and neck cancer, The UCSF experience focusing on target volume delineation. Int. J. Radia. Oncol. Biol. Physi. 2003; 57(1):49-60.
  2. Bucci MK, Bevan A, Roach M. Advances in Radiation therapy conventional to 3 D to IMRT to 4D and beyond. CA cancer. J. Clin. 2005; 55(2):117-34.
  3. Zhang T, Liang ZW, Han J, Bi JP, Yang ZY, Ma H. Double-Arc Volumetric Modulated Therapy Improves Dose Distribution Compared to Static Gantry IMRT and 3D Conformational Radiotherapy for Adjuvant Therapy of Gastric Cancer; Radiation. Oncology. 2015; 10:1-8
  4. Assaoui F, Lachgar A, Benjaafar N. Megavoltage X-Ray Volumetric Modulated Arc-therapy and Multi-Enter Three Dimensional Conformal Radiation Therapy for Prostate Cancer; African Review of Physics 2020; 15: 177-83. 
  5. Ghosh G, Tallari R, Malviya A. Toxicity profile of IMRT Vs 3D-CRT in head and neck cancer: a retrospective study. Journal of clinical and diagnostic research. 2016; 10(9):XC01-XC03.
  6. Shahbazi S, Jangjoo AG, Zamiri RE, Motlagh BN, Mohammadzadeh M, Okutan M, et.al. Prediction of Pituitary Gland Complications by LKB and Log-Logistic Radiobiological Models in 3D Conformal Radiation Therapy of Head and Neck Tumors. Iran J Med Phys. 2021; 18(3):203-10.
  7. Kam MK, Chau RM, Suen J, Choi PH and Teo PM. Intensity-Modulated Radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. International Journal of Radiation Oncology. Physics. 2003; 56(1):145-57.
  8. Palanivelu D, Khanna D, Mohandass P, Panda D, Bhalla NK, Abraham SK, Manoharan M, et.al. Quantitative Analysis of Parotid Sparing and Reducing Xerostomia Using Volumetric Modulated Arc Therapy in Oral Cancer Patients. Iran J Med Phys. 2023; 20(2):100-5.
  9. Bahreyni Toossi MT, Rajab Bolokat E, Raham S, Baiani S, Gholamhoseinian H,  Layegh M, et. al.  An Assessment of Spinal Cord Dose Following Radiotherapy of Nasopharyngeal Cancer by TLD and Rando Phantom. Iranian Journal of Medical Physics. 2009; 6(3, 4):13-8.  
  10. ICRU Report 83, Prescribing, Recording, and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT). Journal of the ICRU. 2010; 10(1):34-5.
  11. Shaw E, Kline R, Gillin M, Souhami L, Hirschfeld A, Dinapoli R. Radiation therapy oncology group: radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys.1993; 27(5):1231-9.
  12. Morgan-Fletcher SL. Prescribing, recording and reporting photon beam therapy (supplement to ICRU Report 50).Report62, International Commission on Radiation Units and Measurements, Washington, DC 1999.
  13. Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S, et.al. Towards multidimentional radiotherapy: Biological imaging & conformity. Int. J. Radia. Oncol. Biol. Physi. 2000; 47(3):551-60.
  14. Ezzal JA, Galvin JM, Low D, Palta JR, Rosen I, Sharpe MB, et.al. Guidance document on delivery, treatment planning and, clinical implementation of IMRT: report of the IMRT subcommittee of the AAPM radiation therapy committee: Medical Physics. 2003; 30(8):2089-115.
  15. Nutting C, Dearnaley DP, Webb S. Intensity modulated radiation therapy: a clinical review. British Journal of radiology 2000; 73(869):459-69.
  16. Clavel S, Nguyen DHA, Fortin B, Després P, Khaouam N, Donath D, et.al. Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma. International Journal of radiation oncology. Biology. Physics. 2012; 82(2):582-9.
  17. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, et.al. IntensityModulated Versus Conventional Radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trials. The lancer Oncology. 2011; 12(2):127-36.
  18. Brahme A, Roos JE, Lax I. Solution of an integral equation encountered in rotation therapy. Physics. Med. Biol. 1982; 27(10):1221-9.
  19. Bratengeier K. 2-Step IMRT and 2-Step IMRT in Three Dimensions. Med. Phys. 2005; 32(12):3849-61.
  20. Otto K. Volumetric Modulated Arc Therapy: IMRT in a single gantry arc. Med. Phys. 2008; 35(1):310-7.
  21. Yu CX. Intensity-modulated arc therapy with dynamic multileaf collimation: and alternative to tomotherapy. Phys. Med. Biol. 1995; 40(9):1435-49.
  22. Baziar O, Gholamhosseinian H, Anvari K. Dose Distribution Evaluation and Independent Quality Check of Spherical INTRABEAM™ Applicators via Radiochromic EBT2 Film Measurement. Iran J Med Phys. 2019; 16(1):139-44.
  23. Krishnan J, Rao S, Hegde S, Shetty J. A dosimetric comparison of double Arc volumetric modulated arc therapy with large field intensity modulated radiation therapy for head and neck cancer. Int. J. Medical Physics, Clinical Enginnering Radiat. Oncol. 2015; 4(4):353-63.
  24. Stieler F, Wolff D, Schmid H, Welzel G, Wenz F, Lohr F. A comparison of several modulated radiotherapy techniques for head and neck cancer and dosimetric validation of VMAT. Radiotherapy and Oncology. 2011; 101(3):388-93.
  25. Venetti E, Cilivio A, Nicolini G, Fogliata A, Ghosh-Laskar S, Agarwal JP. Volumetric modulated arc radiotherapy for carcinoma of the oro-pharynx and larynx: a treatment planning comparison with fixed field IMRT. Radiother. Oncol. 2009; 92(1):111-7.
  26. Bertelsen A, Hansen CR, Johansen J, Brink C. Single Arc Volumetric Arc Therapy of head and neck cancer. Radiotherapy and Oncology. 2010; 95(2):142-8.   
  27. Craman A, Buzea CG, Ojica S, Opera M, Zara AD, Lancu DT. A comparison between 3D conformal radiotherapy, intensity modulated radiotherapy and volumetric modulated Arc-therapy techniques for head and nek cancer. Journal of Advanced Research in Physics. 2016; 6(1):1-5.
  28. Knoos T, Kristensen I, Nilsson P. Volumetric and dosimetric evaluation of radiation treatment plans: radiation conformity index. Int J Radiat Oncol Biol Phys. 1998; 42(5):1169-76.